Based on the transcript, Procter & Gamble's earnings call revealed mixed signals. The company reported strong organic sales growth and market share gains, but commodity costs and market growth challenges remain significant. The guidance for 2012 projects organic sales growth in the range of 3% to 6%, with earnings per share growth of 6% to 10%. Management highlighted the need to improve productivity and cost savings, with a focus on innovation and advertising investments. The stock is likely to face short-term pressure due to tempered guidance and uncertainties around key defense contracts.

**Conclusion:**
The stock is expected to have a neutral impact in the short term due to the mixed signals and uncertainties around commodity costs and market growth.